| Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients M Introna, G Lucchini, E Dander, S Galimberti, A Rovelli, A Balduzzi, ... Biology of blood and marrow transplantation 20 (3), 375-381, 2014 | 263 | 2014 |
| Platelet-lysate-expanded mesenchymal stromal cells as a salvage therapy for severe resistant graft-versus-host disease in a pediatric population G Lucchini, M Introna, E Dander, A Rovelli, A Balduzzi, S Bonanomi, ... Biology of blood and marrow transplantation 16 (9), 1293-1301, 2010 | 238 | 2010 |
| Extracorporeal photochemotherapy is accompanied by increasing levels of circulating CD4+ CD25+ GITR+ Foxp3+ CD62L+ functional regulatory T-cells in patients with graft-versus … E Biagi, I Di Biaso, V Leoni, G Gaipa, V Rossi, C Bugarin, G Renoldi, ... Transplantation 84 (1), 31-39, 2007 | 178 | 2007 |
| Interleukin-17–producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation E Dander, A Balduzzi, G Zappa, G Lucchini, P Perseghin, V Andre, ... Transplantation 88 (11), 1261-1272, 2009 | 164 | 2009 |
| Rituximab as pre-emptive treatment in patients with thrombotic thrombocytopenic purpura and evidence of anti-ADAMTS13 autoantibodies E Bresin, S Gastoldi, E Daina, D Belotti, E Pogliani, P Perseghin, ... Thrombosis and haemostasis 101 (02), 233-238, 2009 | 109 | 2009 |
| Management of poor peripheral blood stem cell mobilization: incidence, predictive factors, alternative strategies and outcome. A retrospective analysis on 2177 patients from … P Perseghin, E Terruzzi, M Dassi, V Baldini, M Parma, P Coluccia, ... Transfusion and Apheresis Science 41 (1), 33-37, 2009 | 107 | 2009 |
| Regulatory T cells and extracorporeal photochemotherapy: correlation with clinical response and decreased frequency of proinflammatory T cells I Di Biaso, L Di Maio, C Bugarin, G Gaipa, E Dander, A Balduzzi, M Parma, ... Transplantation 87 (9), 1422-1425, 2009 | 98 | 2009 |
| Effectiveness of leukocyte filters in reducing tumor cell contamination after intraoperative blood salvage in lung cancer patients P Perseghin, M Vigano, G Rocco, C Della Pona, A Buscemi, A Rizzi Vox sanguinis 72 (4), 221-224, 1997 | 92 | 1997 |
| Extracorporeal photopheresis for the treatment of acute and chronic graft‐versus‐host disease in adults and children: best practice recommendations from an I talian S ociety of … L Pierelli, P Perseghin, M Marchetti, C Messina, C Perotti, A Mazzoni, ... Transfusion 53 (10), 2340-2352, 2013 | 89 | 2013 |
| Best practice for peripheral blood progenitor cell mobilization and collection in adults and children: results of a Società Italiana Di Emaferesi e Manipolazione Cellulare … L Pierelli, P Perseghin, M Marchetti, P Accorsi, R Fanin, C Messina, ... Transfusion 52 (4), 893-905, 2012 | 88* | 2012 |
| Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring E Dander, G Lucchini, P Vinci, M Introna, F Masciocchi, P Perseghin, ... Leukemia 26 (7), 1681-1684, 2012 | 76 | 2012 |
| Donor lymphocyte infusion after allogeneic stem cell transplantation L Castagna, B Sarina, S Bramanti, P Perseghin, J Mariotti, L Morabito Transfusion and Apheresis Science 54 (3), 345-355, 2016 | 73 | 2016 |
| Characterization of platelet lysate cultured mesenchymal stromal cells and their potential use in tissue-engineered osteogenic devices for the treatment of bone defects A Salvade, PD Mina, D Gaddi, F Gatto, A Villa, M Bigoni, P Perseghin, ... Tissue Engineering Part C: Methods 16 (2), 201-214, 2010 | 73 | 2010 |
| Extracorporeal photochemotherapy for the treatment of chronic graft‐versus‐host disease: trend for a possible cell dose‐related effect? P Perseghin, S Galimberti, A Balduzzi, S Bonanomi, V Baldini, A Rovelli, ... Therapeutic Apheresis and Dialysis 11 (2), 85-93, 2007 | 69 | 2007 |
| Rituximab prevents recurrence of thrombotic thrombocytopenic purpura: a case report M Galbusera, E Bresin, M Noris, S Gastoldi, D Belotti, C Capoferri, ... Blood 106 (3), 925-928, 2005 | 69 | 2005 |
| Phase II study of sequential infusion of donor lymphocyte infusion and cytokine-induced killer cells for patients relapsed after allogeneic hematopoietic stem cell transplantation M Introna, F Lussana, A Algarotti, E Gotti, R Valgardsdottir, C Micò, ... Biology of Blood and Marrow Transplantation 23 (12), 2070-2078, 2017 | 58 | 2017 |
| Erythrocytapheresis plus erythropoietin: an alternative therapy for selected patients with hemochromatosis and severe organ damage R Mariani, S Pelucchi, P Perseghin, C Corengia, A Piperno Haematologica 90 (5), 717-718, 2005 | 53 | 2005 |
| Mesenchymal stromal cells do not increase the risk of viral reactivation nor the severity of viral events in recipients of allogeneic stem cell transplantation G Lucchini, E Dander, F Pavan, I Di Ceglie, A Balduzzi, P Perseghin, ... Stem Cells International 2012, 2012 | 44 | 2012 |
| Allogeneic bone marrow stem cell transplantation following CD34+ immunomagnetic enrichment in patients with inherited metabolic storage diseases G Gaipa, M Dassi, P Perseghin, N Venturi, P Corti, S Bonanomi, ... Bone marrow transplantation 31 (10), 857-860, 2003 | 42 | 2003 |
| Mononuclear cell collection in patients undergoing extra‐corporeal photo‐chemotherapy for acute and chronic graft‐vs.‐host‐disease (GvHD): comparison between COBE Spectra … P Perseghin, M Dassi, A Balduzzi, A Rovelli, S Bonanomi, C Uderzo Journal of Clinical Apheresis: The Official Journal of the American Society …, 2002 | 41 | 2002 |
Alessandro RambaldiProfessore di Ematologia, Università degli Studi di MilanoE-mail confirmado em unimi.it
